Prestige Consumer Healthcare Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 570

Employees

  • Stock Symbol
  • PBH

Stock Symbol

  • Investments
  • 27

  • Share Price
  • $64.65
  • (As of Friday Closing)

Prestige Consumer Healthcare General Information

Description

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Contact Information

Formerly Known As
Medtech, Medtech Holdings, Inc., Prestige Brands, Prestige Brands, Inc.
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Distributors (Healthcare)
Stock Exchange
NYS
Corporate Office
  • 4615 Murray Place
  • Lynchburg, VA 24502
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prestige Consumer Healthcare Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$64.65 $64.98 $55.96 - $75.31 $3.23B 49.9M 237K $4.21

Prestige Consumer Healthcare Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 4,752,448 4,752,448 4,473,290 4,198,203
Revenue 1,125,357 1,125,357 1,127,725 1,086,812
EBITDA 373,860 373,860 7,874 358,837
Net Income 209,339 209,339 (82,306) 205,381
Total Assets 3,318,417 3,318,417 3,353,729 3,670,681
Total Debt 1,139,656 1,139,656 1,367,091 1,506,359
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Prestige Consumer Healthcare Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prestige Consumer Healthcare‘s full profile, request access.

Request a free trial

Prestige Consumer Healthcare Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse por
Personal Products
Lynchburg, VA
570 As of 2024
00.000
000000000 00.000

000000

ercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute ir
000000000000000
Gurugram, India
0000 As of 0000
00000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Prestige Consumer Healthcare Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glaxosmithkline Consumer Healthcare Corporate Backed or Acquired Gurugram, India 0000 000000&0
You’re viewing 1 of 1 competitors. Get the full list »

Prestige Consumer Healthcare Patents

Prestige Consumer Healthcare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230277387-A1 Pad and method of use for removing callus Pending 03-Mar-2022 0000000000
CA-3139734-A1 Borate ester complexes of a-hydroxy carboxylic acids and their conjugate base buffers Pending 23-Nov-2020 0000000000
US-20220162234-A1 Borate ester complexes of a-hydroxy carboxylic acids and their conjugate base buffers Pending 23-Nov-2020 0000000000
US-10426834-B1 Methods of sterilizing drugs Inactive 11-Aug-2016 000000000 0
US-9517269-B1 Stable pentobarbital formulation Active 01-Oct-2013 A61K47/10
To view Prestige Consumer Healthcare’s complete patent history, request access »

Prestige Consumer Healthcare Executive Team (13)

Name Title Board Seat Contact Info
Ronald Lombardi President, Chief Executive Officer & Chairman
Christine Sacco Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Adel Mekhail Executive Vice President
Jeffrey Zerillo Executive Vice President
William P'Pool JD General Counsel, Legal & Secretary, Administration
You’re viewing 5 of 13 executive team members. Get the full list »

Prestige Consumer Healthcare Board Members (9)

Name Representing Role Since
0000000 00000 00.0 Self Board Member 000 0000
00000000000 000000 Self Board Member 000 0000
0000 0000 Prestige Consumer Healthcare Board Member 000 0000
000000 000000000 Self Board Member 000 0000
000000 00000000 Prestige Consumer Healthcare President, Chief Executive Officer & Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Prestige Consumer Healthcare Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prestige Consumer Healthcare Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Prestige Consumer Healthcare‘s full profile, request access.

Request a free trial

Prestige Consumer Healthcare Investments & Acquisitions (27)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Akorn (Consumer Health Business) 01-Jul-2021 0000000000 00000 Pharmaceuticals
TheraTears 01-Jul-2021 0000000000 00000 Pharmaceuticals 000000 00
Fleet Laboratories 26-Jan-2017 0000000000 00000 Pharmaceuticals 000000 00
DenTek Oral Care 05-Feb-2016 0000000000 00000 Personal Products 000000 00
Insight Pharmaceuticals 03-Sep-2014 Merger/Acquisition 00000 Pharmaceuticals
You’re viewing 5 of 27 investments and acquisitions. Get the full list »

Prestige Consumer Healthcare Subsidiaries (7)

Company Name Industry Location Founded
Hydralyte Pharmaceuticals San Diego, CA 2001
TheraTears Pharmaceuticals Ann Arbor, MI 0000
Care Pharmaceuticals Pharmaceuticals Bondi Junction, Australia 0000
DenTek Oral Care Personal Products Maryville, TN 0000
Chloraseptic Pharmaceuticals Tarrytown, NY 0000
You’re viewing 5 of 7 subsidiaries. Get the full list »

Prestige Consumer Healthcare ESG

Risk Overview

Risk Rating

Updated April, 24, 2024

29.85 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,421

Rank

00.0

Percentile

Pharmaceuticals

Industry

00 of 928

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 456

Rank

00.00

Percentile

To view Prestige Consumer Healthcare’s complete esg history, request access »

Prestige Consumer Healthcare Exits (7)

Company Name Exit Date Exit Type Exit Size Status Buyers
Hydralyte 02-May-2014 000000000000000000 0000 Completed
  • 00000000 00000000
Chore Boy 28-Oct-2005 000000000000000000 000.00 Completed
  • 00000000 00000000
Comet Cleanser 01-Oct-2001 0000000000 Completed
  • 3 buyers
Cutex Brands 01-Dec-1998 0000000000 Completed
  • 2 buyers
New Skin 01-Jan-1996 Buyout/LBO Completed
  • 2 buyers
You’re viewing 5 of 7 exits. Get the full list »

Prestige Consumer Healthcare FAQs

  • When was Prestige Consumer Healthcare founded?

    Prestige Consumer Healthcare was founded in 1996.

  • Who is the CEO of Prestige Consumer Healthcare?

    Ronald Lombardi is the CEO of Prestige Consumer Healthcare.

  • Where is Prestige Consumer Healthcare headquartered?

    Prestige Consumer Healthcare is headquartered in Lynchburg, VA.

  • What is the size of Prestige Consumer Healthcare?

    Prestige Consumer Healthcare has 570 total employees.

  • What industry is Prestige Consumer Healthcare in?

    Prestige Consumer Healthcare’s primary industry is Personal Products.

  • Is Prestige Consumer Healthcare a private or public company?

    Prestige Consumer Healthcare is a Public company.

  • What is Prestige Consumer Healthcare’s stock symbol?

    The ticker symbol for Prestige Consumer Healthcare is PBH.

  • What is the current stock price of Prestige Consumer Healthcare?

    As of 17-May-2024 the stock price of Prestige Consumer Healthcare is $64.65.

  • What is the current market cap of Prestige Consumer Healthcare?

    The current market capitalization of Prestige Consumer Healthcare is $3.23B.

  • What is Prestige Consumer Healthcare’s current revenue?

    The trailing twelve month revenue for Prestige Consumer Healthcare is $1.13B.

  • Who are Prestige Consumer Healthcare’s competitors?

    Glaxosmithkline Consumer Healthcare is a competitor of Prestige Consumer Healthcare.

  • What is Prestige Consumer Healthcare’s annual earnings per share (EPS)?

    Prestige Consumer Healthcare’s EPS for 12 months was $4.21.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »